FCF co-hosted the “ACCESS CHINA Summer Showcase” – the largest online corporate access event between China and Western Biopharma Industry – from June 9th to 18th, 2021.
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand into the Chinese market. The event will help western biopharma companies to efficiently present their assets online in front of 500+ biopharma companies and healthcare VCs in China. It creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. Over 1,000 attendees participated to present more than 50 partnering opportunities from the U.S., Europe, Japan, Korea, and China.
The online event was divided into 4 sessions:
- Global Out-Licensing Session
Global pharmas looking for out-licensing opportunities in China
- China Biotech Out-Licensing Session
Chinese biotech looking for global out-licensing & partnering opportunities
- China Asset M&A Session
Chinese pharmas looking for domestic M&A and out-licensing opportunities
- China Biotech Fundraising Session
Chinese Biotech companies looking for fundraising